Inventor · disambiguated record
Kay-Gunnar Stubenrauch
Also filed as: STUBENRAUCH KAY-GUNNAR
36 granted patents·18 pending applications·346 citations·filing 2000–2024
97Inventor score
Top patents by PatentIndex Score
54 records- 0197US9695233B2Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseasesROCHE GLYCART AG·Filed 2013·Granted Jul 4, 2017·44 cites·11 claims
- 0297US7563441B2Anti-P-selectin antibodiesHOFFMANN LA ROCHE·Filed 2005·Granted Jul 21, 2009·94 cites·34 claims
- 0394US8945552B2Bispecific, bivalent anti-VEGF/anti-ANG-2 antibodiesBAEHNER MONIKA·Filed 2011·Granted Feb 3, 2015·36 cites·12 claims
- 0493US10761097B2Method for the detection of a binding partner of a multispecific binderHOFFMANN LA ROCHE·Filed 2018·Granted Sep 1, 2020·5 cites·6 claims
- 0592US11913945B2Method for determining the amount of a therapeutic antibody in the brainHOFFMANN LA ROCHE·Filed 2020·Granted Feb 27, 2024·3 cites·14 claims
- 0692US10168326B2Interference-suppressed immunoassay to detect anti-drug antibodies in serum samplesHOFFMANN LA ROCHE·Filed 2016·Granted Jan 1, 2019·11 cites·7 claims
- 0791US10683345B2Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseasesROCHE GLYCART AG·Filed 2017·Granted Jun 16, 2020·5 cites·16 claims
- 0891US8530176B2Distinguishing assaySTUBENRAUCH KAY-GUNNAR·Filed 2012·Granted Sep 10, 2013·18 cites·11 claims
- 0991US8227195B2Distinguishing assaySTUBENRAUCH KAY-GUNNAR·Filed 2008·Granted Jul 24, 2012·25 cites·4 claims
- 1091US7824684B2Methods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodiesHOFFMANN LA ROCHE·Filed 2010·Granted Nov 2, 2010·14 cites·20 claims
- 1190US10761091B2Interference-suppressed immunoassay to detect anti-drug antibodies in serum samplesHOFFMANN LA ROCHE·Filed 2018·Granted Sep 1, 2020·3 cites·6 claims
- 1290US7807158B2Antibodies against IL-13 receptor alpha1 and uses thereofROCHE PALO ALTO LLC·Filed 2006·Granted Oct 5, 2010·19 cites·9 claims
- 1389US9945869B2Method for the detection of a binding partner of a multispecific binderHOFFMANN LA ROCHE·Filed 2014·Granted Apr 17, 2018·6 cites·8 claims
- 1489US6437095B1Method for producing chimeric polypeptidesHOFFMANN LA ROCHE·Filed 2000·Granted Aug 20, 2002·41 cites·17 claims
- 1588US7754867B2Nucleic acid molecules encoding anti-P-selectin antibodiesHOFFMANN LA ROCHE·Filed 2009·Granted Jul 13, 2010·8 cites·42 claims
- 1687US11679127B2Antigen binding receptors specific for mutated Fc domainsHOFFMANN LA ROCHE·Filed 2019·Granted Jun 20, 2023·3 cites·31 claims
- 1781US2023111088A1Anti-drug antibody assayHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1880US9671394B2Method for the detection of free binding partner of a multispecific binderHOFFMANN LA ROCHE·Filed 2014·Granted Jun 6, 2017·3 cites·26 claims
- 1980US2023212277A1Bispecific anti-vegf/anti-ang-2 antibodies and their use in the treatment of ocular vascular diseasesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2079US2024219381A1Method for determining the amount of a therapeutic antibody in the brainHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 2177US11340234B2Method for the determination of anti-drug antibodies against an effector function suppressed human or humanized drug antibodyHOFFMANN LA ROCHE·Filed 2017·Granted May 24, 2022·1 cites·19 claims
- 2277USRE43568EAnti-P-selectin antibodiesGRAUS YVO·Filed 2011·Granted Aug 7, 2012·3 cites·141 claims
- 2375US9933433B2Anti-drug antibody assayHOFFMANN LA ROCHE·Filed 2014·Granted Apr 3, 2018·1 cites·5 claims
- 2475US2023119537A1Protease-activated t cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2573US12291561B2Antigen binding receptors specific for mutated Fc domainsHOFFMANN LA ROCHE·Filed 2023·Granted May 6, 2025·0 cites·28 claims
- 2673US2022275087A1Protease-activated t cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 2772US2022357340A1Method for determining the amount of a therapeutic antibody in the brainHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 2871US9766251B2Anti-human IgG1 antibodyHOFFMANN LA ROCHE·Filed 2015·Granted Sep 19, 2017·1 cites·26 claims
- 2969USRE44359ENucleic acid molecules encoding anti-P-selectin antibodiesGRAUS YVO·Filed 2012·Granted Jul 9, 2013·1 cites·169 claims
- 3069US2021095013A1Bispecific anti-vegf/anti-ang-2 antibodies and their use in the treatment of ocular vascular diseasesROCHE GLYCART AG·Filed 2020·Application pending·0 cites
- 3168US2021055304A1Method for the detection of a binding partner of a multispecific binderHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 3268US2019170765A1Anti-drug antibody assayHOFFMANN LA ROCHE·Filed 2018·Application pending·0 cites
- 3366US11970550B2Anti-variant Fc-region antibodies and method of useHOFFMANN LA ROCHE·Filed 2020·Granted Apr 30, 2024·0 cites·6 claims
- 3465US8614297B2Anti-idiotype antibody against an antibody against the amyloid β peptideESSIG ULRICH·Filed 2009·Granted Dec 24, 2013·0 cites·1 claims
- 3564US11242390B2Protease-activated T cell bispecific moleculesHOFFMANN LA ROCHE·Filed 2018·Granted Feb 8, 2022·0 cites·5 claims
- 3664US10899845B2Anti-variant Fc-region antibodies and method of useHOFFMANN LA ROCHE·Filed 2018·Granted Jan 26, 2021·0 cites·6 claims
- 3764US8809005B2Conjugate and its use as a standard in an immunoassaySTUBENRAUCH KAY-GUNNAR·Filed 2007·Granted Aug 19, 2014·1 cites·8 claims
- 3860USRE44389EMethods of inhibiting the binding of P-selectin to PSGL-1 with anti-P-selectin antibodiesHOFFMANN LA ROCHE·Filed 2012·Granted Jul 23, 2013·0 cites·81 claims
- 3960US2023131782A1Ada-response specification assayHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 4059US2015191535A1Bispecific, bivalent anti-vegf/anti-ang2 antibodiesHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 4159US2015253338A1Anti-drug antibody assayHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 4258US9547010B2Anti-idiotype antibody against an antibody against the amyloid β peptideHOFFMANN LA ROCHE·Filed 2013·Granted Jan 17, 2017·0 cites·4 claims
- 4353US2009061466A1Anti-drug antibody assayHOESEL WOLFGANG·Filed 2007·Application pending·0 cites
- 4453US2010041063A1Anti-drug antibody assayESSIG ULRICH·Filed 2007·Application pending·0 cites
- 4552US2014038210A1ANTI-HUMAN IgG1 ANTIBODYHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 4651US2017240626A1Bispecific, bivalent anti-vegf/anti-ang-2 antibodiesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 4749US11561229B2Immunoassay for the determination of Fc-region modified antibodiesHOFFMANN LA ROCHE·Filed 2018·Granted Jan 24, 2023·0 cites·6 claims
- 4849US11313864B2Method for determining anti-drug antibodies in a minipig sampleHOFFMANN LA ROCHE·Filed 2020·Granted Apr 26, 2022·0 cites·15 claims
- 4949US2020093861A1Antigen binding receptor formatsHOFFMANN LA ROCHE·Filed 2019·Application pending·0 cites
- 5047US9957331B2Non-cross-reactive anti IgG antibodiesESSIG ULRICH·Filed 2010·Granted May 1, 2018·0 cites·12 claims
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kay-Gunnar Stubenrauch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →